Drugs & Pharmaceuticals M&A » By The Online Investor Staff, updated Fri., Jun. 9, 8:05 AM
Recent mergers and acquisitions in the Drugs & Pharmaceuticals M&A category.
| This Slide: #87 of 100 |
Slide #87. Prestige Brands Holdings, Inc. — Care Pharmaceuticals
Acquirer:
Prestige Brands Holdings, Inc. (NYSE:PBH)
Acquiree:
Care Pharmaceuticals
Details:
Prestige Brands Holdings, Inc. (NYSE:PBH) today announced its acquisition of Care Pharmaceuticals Pty Ltd. ("Care") of Bondi Junction, New South Wales, Australia, a privately-held marketer and distributor of over-the-counter (OTC) healthcare brands for children and adults. The acquisition is effective July 1, 2013.
Prestige Consumer Healthcare is a holding company. Through its subsidiaries, Co. is engaged in the development, manufacturing, marketing, sales, and distribution of over-the-counter (OTC) health and personal care products. Co. conducts its operations in two reportable segments: North American OTC Healthcare and International OTC Healthcare. Co.'s brands in the North American OTC Healthcare segment include Boudreaux's Butt Paste baby ointments with products that include various diaper rash treatments and skin protectants. Co.'s brands in the International OTC Healthcare segment include Fess nasal saline sprays and washes.
PBH SEC Filing Email Alerts Service
Open the PBH Page at The Online Investor »
|
||||||||||||||||||||||||
Open the PBH Page at The Online Investor (in a new window) »
 Free PBH Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
 
|
Buy (3.33 out of 4) 46th percentile
(ranked lower than approx. 54% of all stocks covered)
Analysts' Target Price: PBH Stock Forecast Based on Zacks ABR data; powered by Xignite |
